Stockreport

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance [Yahoo! Finance]

LakeShore Biopharma Co., Ltd - Ordinary Shares  (LSB) 
PDF Achieved gross profit of RMB 307.3 million, a growth of 39.1% YoY Gross margin increased to 82.6% from 80.9% in the same period of FY2024 Total operating expenses d [Read more]